|
1
|
Nordlinger B, Sorbye H, Glimelius B,
Poston GJ, Schlag PM, Rougier P, Bechstein WO, Primrose JN, Walpole
ET, Finch-Jones M, et al: Perioperative chemotherapy with FOLFOX4
and surgery versus surgery alone for resectable liver metastases
from colorectal cancer (EORTC Intergroup trial 40983): A randomised
controlled trial. Lancet. 371:1007–1016. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wan D: Epidemiology and prevention of
colorectal cancer. Chin J Surg Integ Tradit West Med. 17:3–7.
2012.
|
|
6
|
Galizia G, Gemei M, Del Vecchio L, Zamboli
A, Di Noto R, Mirabelli P, Salvatore F, Castellano P, Orditura M,
De Vita F, et al: Combined CD133/CD44expression as a prognostic
indicator of disease-free survival in patientswith colorectal
cancer. Arch Surg. 147:18–24. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
The changing face of UK primary cancer
care: Lancet Oncol. 2:6492001.
|
|
8
|
Speights VO, Johnson MW, Stoltenberg PH,
Rappaport ES, Helbert B and Riggs M: Colorectal cancer: Current
trends in initial clinical manifestations. South Med J. 84:575–578.
1991.PubMed/NCBI
|
|
9
|
Summerton N: Symptoms of possible
oncological significance: Separating the wheat from the chaff. BMJ.
325:1254–1255. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Flashman K, O'Leary DP, Senapati A and
Thompson MR: The department of health's ‘two week standard’ for
bowel cancer: Is it working? Gut. 53:387–391. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Knottnerus JA, Knipschild PG and Sturmans
F: Symptoms and selection bias: The influence of selection towards
specialist care on the relatioship between symptoms and diagnosis.
Theor Med. 10:67–81. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
LaPointe LC, Pedersen SK, Dunne R, Brown
GS, Pimlott L, Gaur S, McEvoy A, Thomas M, Wattchow D, Molloy PL,
et al: Discovery and validation of molecular biomarkers for
colorectal adenomas and cancer with application to blood testing.
PLoS One. 7:e290592012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yi JM, Dhir M, Guzzetta AA,
Iacobuzio-Donahue CA, Heo K, Yang KM, Suzuki H, Toyota M, Kim HM,
Ahuja N, et al: DNA methylation biomarker candidates for early
detection of colon cancer. Tumour Biol. 33:363–72. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gautier L, Cope L, Bolstad BM and Irizarry
RA: Affy-analysis of Affymetrix GeneChip data at the probe level.
Bioinformatics. 20:307–315. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wright JB, Brown SJ and Cole MD:
Upregulation of c-MYC in cis through a large chromatin loop linked
to a cancer risk-associated single-nucleotide polymorphism in
colorectal cancer cells. Mol Cell Biol. 30:1411–1420. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
de Hoon MJ, Imoto S, Nolan J and Miyano S:
Open source clustering software. Bioinformatics. 20:1453–1454.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Maitra A, Adsay NV, Argani P,
Iacobuzio-Donahue C, De Marzo A, Cameron JL, Yeo CJ and Hruban RH:
Multicomponent analysis of the pancreatic adenocarcinoma
progression model using a pancreatic intraepithelial neoplasia
tissue microarray. Mod Pathol. 16:902–912. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Huber W, Von Heydebreck A and Vingron M:
Analysis of microarray gene expression dataHandbook of Statistical
Genetics. 2nd. John Wiley & Sons; (NJ, USA): pp. 37–53.
2003
|
|
20
|
National Cancer Centre, . Bureau for
Disease Control and Prevention of Health Ministry: The 2011 Chinese
cancer registry annual report. Military Medical Science Press 17;
Beijing: 53–57(58)2012, (In Chinese).
|
|
21
|
Chen JG, Zhu J, Parkin DM, Zhang YH, Lu
JH, Zhu YR and Chen TY: Trends in the incidence of cancer in
Qidong, China, 1978–2002. Int J Cancer. 119:1447–1454. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xu J, Qin X, Wang J, Zhang S, Zhong Y, Ren
L, Wei Y, Zeng S, Wan D, Zheng S, et al: Chinese guidelines for the
diagnosis and comprehensive treatment of hepatic metastasis of
colorectal cancer. J Cancer Res Clin Oncol. 137:1379–1396. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fearon ER: Molecular genetics of
colorectal cancer. Annu Rev Pathol. 6:479–507. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Quackenbush J: Computational analysis of
microarray data. Nat Rev Genet. 2:418–427. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang X, Gong Y, Wang D, Xie Q, Zheng M,
Zhou Y, Li Q, Yang Z, Tang H, Li Y, et al: Analysis of gene
expression profiling in meningioma: Deregulated signaling pathways
associated with meningioma and EGFL6 overexpression in benign
meningioma tissue and serum. PLoS One. 7:e527072012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fang XQ, Liu XF, Yao L, Chen CQ, Gu ZD, Ni
PH, Zheng XM and Fan QS: Somatic mutational analysis of FAK in
breast cancer: A novel gain-of-function mutation due to deletion of
exon 33. Biochem Biophys Res Commun. 443:363–369. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu J, Zhang C and Feng Z: Tumor
suppressor p53 and its gain-of-function mutants in cancer. Acta
Biochim Biophys Sin (Shanghai). 46:170–179. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Colli LM, Saggioro F, Serafini LN, Camargo
RC, Machado HR, Moreira AC, Antonini SR and de Castro M: Components
of the canonical and non-canonical Wnt pathways are not
mis-expressed in pituitary tumors. PLoS One. 8:e624242013.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cai Y, Cai T and Chen Y: Wnt pathway in
osteosarcoma, from oncogenic to therapeutic. J Cell Biochem.
115:625–631. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang SH, Li N, Wei Y, Li QR and Yu ZP:
β-catenin deacetylation is essential for WNT-induced proliferation
of breast cancer cells. Mol Med Rep. 9:973–978. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Krausova M and Korinek V: Wnt signaling in
adult intestinal stem cells and cancer. Cell Signal. 26:570–579.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Waterman ML: Lymphoid enhancer factor/T
cell factor expression in colorectal cancer. Cancer Metastasis Rev.
23:41–52. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tetsu O and McCormick F: Beta-catenin
regulates expression of cyclin D1 in colon carcinoma cells. Nature.
398:422–426. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
34
|
Emaduddin M, Bicknell DC, Bodmer WF and
Feller SM: Cell growth, global phosphotyrosine elevation, and c-Met
phosphorylation through Src family kinases in colorectal cancer
cells. Proc Natl Acad Sci USA. 105:2358–2362. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kriegl L, Horst D, Reiche JA, Engel J,
Kirchner T and Jung A: LEF-1 and TCF4 expression correlate
inversely with survival in colorectal cancer. J Transl Med.
8:1232010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Liu W, Dong X, Mai M, Seelan RS, Taniguchi
K, Krishnadath KK, Halling KC, Cunningham JM, Boardman LA, Qian C,
et al: Mutations in AXIN2 cause colorectal cancer with defective
mismatch repair by activating beta-catenin/TCF signalling. Nat
Genet. 26:146–147. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
37
|
He TC, Sparks AB, Rago C, Hermeking H,
Zawel L, da Costa LT, Morin PJ, Vogelstein B and Kinzler KW:
Identification of c-MYC as a Target of the APC Pathway. Science.
281:1509–1512. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Mao CD and Byers SW: Cell-context
dependent TCF/LEF expression and function: Alternative tales of
repression, de-repression and activation potentials. Crit Rev
Eukaryot Gene Expr. 21:207–236. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wang FW, Wen L, Zhu SW, Yao Q, Cai YM and
Ma G: Mechanism of Wnt signaling pathway regulation by a truncated
mutant of Axin2 in colorectal cancer. Cancer. 26:1041–1046.
2007.(In Chinese).
|
|
40
|
van de Wetering M, Sancho E, Verweij C, de
Lau W, Oving I, Hurlstone A, van der Horn K, Batlle E, Coudreuse D,
Haramis AP, et al: The beta-catenin/TCF-4 complex imposes a crypt
progenitor phenotype on colorectal cancer cells. 111:241–250.
2002.
|
|
41
|
Wang Y and Zheng T: Screening of hub genes
and pathways in colorectal cancer with microarray technology.
Pathol Oncol Res. 20:611–618. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Nishimura Y, Takiguchi S, Ito S and Itoh
K: Evidence that depletion of the sorting nexin 1 by siRNA promotes
HGF-induced MET endocytosis and MET phosphorylation in a
gefitinib-resistant human lung cancer cell line. Int J Oncol.
44:412–426. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Naushad SM, Reddy CA, Kumaraswami K,
Divyya S, Kotamraju S, Gottumukkala SR, Digumarti RR and Kutala VK:
Impact of hyperhomocysteinemia on breast cancer initiation and
progression: Epigenetic perspective. Cell Biochem Biophys.
68:397–406. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Han L, Wu Z and Zhao Q: Revealing the
molecular mechanism of colorectal cancer by establishing
LGALS3-related protein-protein interaction network and identifying
signaling pathways. Int J Mol Med. 33:581–588. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Takahashi Y, Sawada G, Kurashige J, Uchi
R, Matsumura T, Ueo H, Takano Y, Eguchi H, Sudo T, Sugimachi K, et
al: Amplification of PVT-1 is involved in poor prognosis via
apoptosis inhibition in colorectal cancers. Br J Cancer.
110:164–171. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Gantt GA, Chen Y, Dejulius K, Mace AG,
Barnholtz-Sloan J and Kalady MF: Gene expression profile is
associated with chemoradiation resistance in rectal cancer.
Colorectal Dis. 16:57–66. 2014. View Article : Google Scholar : PubMed/NCBI
|
